Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-03

Clinical Trial Update: A Survey to Assess Participants', Caregivers', and Nurses' Use and Understanding of Educational Material on Velaglucerase Alfa (VPRIV) Home Infusion

View source ↗

Summary

A survey is being conducted to evaluate how participants, caregivers, and nurses use and understand educational materials for Velaglucerase alfa home infusion i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VPRIV (VELAGLUCERASE ALFA)

Snippet

Sponsor: Takeda | Conditions: Gaucher Disease | Status: NOT_YET_RECRUITING